Tocilizumab reduces hypercoagulation in COVID-19 – Perspectives from the coagulation and immunomodulation Covid assessment (Coag-ImmCovA) clinical trial
Tocilizumab reduces hypercoagulation in COVID-19 – Perspectives from the coagulation…
Ler MaisArtigos recentes
- TO INFORM OR NOT TO INFORM about venous thromboembolisms – A qualitative study on communication between healthcare professionals and patients with lung cancer
- Tocilizumab reduces hypercoagulation in COVID-19 – Perspectives from the coagulation and immunomodulation Covid assessment (Coag-ImmCovA) clinical trial
- Regulation of fibrinogen synthesis
- The Attend-PE model: A feasibility study of a structured follow-up care model for patients with pulmonary embolism
- Venous thromboembolism in the era of machine learning and artificial intelligence in medicine
Cometários recentes
Nenhum comentário para mostrar.
Categorias
- Acta Médica Portuguesa
- Angiologia e Cirurgia Vascular
- artigo cientifico
- artigo revisão
- Blood
- Blood Advances
- Blood Coagulation & Fibrinolysis
- British Journal of Haematology
- Clinical and Applied Thrombosis / Hemostasis
- Clinical Case Reports
- European Heart Journal – Cardiovascular Pharmacotherapy
- European Journal of Case Reports in Internal Medicine
- Haemophilia
- Journal of Clinical Medicine
- Journal of Thrombosis and Haemostasis
- meta-analise
- New England Journal of Medicine
- noticias
- primeira reunião APTH
- Revista Portuguesa de Cardiologia
- The Lancet Haematology
- Thrombosis Research